1
Department of Biochemistry and Molecular Biology 2013 Seminar Series Wednesday 27 th March, 4pm Lecture Theatre M2, Building 13A Associate Professor Kevin Pfleger Western Australian Institute for Medical Research New insights into the molecular pharmacology of receptor complexes Kevin Pfleger is an ARC Future Fellow, Head of Molecular Endocrinology– GPCRs at the Western Australian Institute for Medical Research and Chief Scientific Officer of Dimerix Bioscience, a spin-out company from UWA. He has made important discoveries about the molecular pharmacology, arrestin interactions and heterodimerisation of G protein-coupled receptors and has developed novel bioluminescence resonance energy transfer (BRET) methodology for detection of GPCR-ligand

Department of Biochemistry and Molecular Biology 2013 Seminar Series Wednesday 27 th March, 4pm

Embed Size (px)

DESCRIPTION

Department of Biochemistry and Molecular Biology 2013 Seminar Series Wednesday 27 th March, 4pm Lecture Theatre M2, Building 13A. Associate Professor Kevin Pfleger Western Australian Institute for Medical Research New insights into the molecular pharmacology of receptor complexes. - PowerPoint PPT Presentation

Citation preview

Page 1: Department of Biochemistry and Molecular Biology 2013 Seminar Series Wednesday 27 th  March, 4pm

Department of Biochemistry and Molecular Biology

2013 Seminar SeriesWednesday 27th March, 4pm

Lecture Theatre M2, Building 13A

Associate Professor Kevin PflegerWestern Australian Institute for Medical Research

New insights into the molecular pharmacology of receptor complexes

Kevin Pfleger is an ARC Future Fellow, Head of Molecular Endocrinology–GPCRs at the Western Australian Institute for Medical Research and Chief Scientific Officer of Dimerix Bioscience, a spin-out company from UWA. He has made important discoveries about the molecular pharmacology, arrestin interactions and heterodimerisation of G protein-coupled receptors and has developed novel bioluminescence resonance energy transfer (BRET) methodology for detection of GPCR-ligand interactions.